stocksBETA
BETA

Beta Drugs Ltd.

2,315.60+38.4 (+1.69%)
24 Jul, 12:00 AM

Annual Reports and Financial Documents

Beta Drugs Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2023202420252026
Annual Reports
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Beta Drugs Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Reply to Clarification- Financial results23 Jul 2026
    The Exchange had sought clarification from Beta Drugs Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
  • Copy of Newspaper Publication21 Jul 2026
    Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication
  • Statement of deviation(s) or variation(s) under Reg. 3220 Jul 2026
    Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Outcome of Board Meeting20 Jul 2026
    Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
  • Certificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026
    Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Trading Window30 Jun 2026
    Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Spurt in Volume15 Jun 2026
    Significant increase in volume has been observed in Beta Drugs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Beta Drugs Limited has submitted their response.
  • General Updates25 May 2026
    Beta Drugs Limited has informed the Exchange about Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Completion of Acquisition of Shares of Nivian Lifesciences Private Limited
  • Outcome of Board Meeting25 May 2026
    Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25, 2026.
  • Analysts/Institutional Investor Meet/Con. Call Updates22 May 2026
    Beta Drugs Limited has informed the Exchange about Transcript
  • Copy of Newspaper Publication16 May 2026
    Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication
  • Analysts/Institutional Investor Meet/Con. Call Updates15 May 2026
    Beta Drugs Limited has informed the Exchange about Presentation
  • Statement of deviation(s) or variation(s) under Reg. 3214 May 2026
    Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Monitoring Agency Report14 May 2026
    Monitoring Agency Report for the Quarter ended 31st March, 2026
  • Outcome of Board Meeting14 May 2026
    Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Analysts/Institutional Investor Meet/Con. Call Updates12 May 2026
    Beta Drugs Limited has informed the Exchange about Schedule of meet
  • Outcome of Board Meeting25 Apr 2026
    Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on April 25, 2026.
  • General Updates22 Apr 2026
    Beta Drugs Limited has informed the Exchange about Beta Drugs Expands International Market Access with Key Regulatory Milestones in Azerbaijan and Philippines.
  • Disclosure under SEBI Takeover Regulations7 Apr 2026
    Beta Drugs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
  • Price movement7 Apr 2026
    Significant movement in price has been observed in Beta Drugs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Beta Drugs Limited has submitted their response.

Frequently Asked Questions

Where can I download the annual report of Beta Drugs Ltd.?
Annual reports of Beta Drugs Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Beta Drugs Ltd.?
Quarterly earnings results and presentations of Beta Drugs Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Beta Drugs Ltd. publish earnings call transcripts?
Earnings call transcripts of Beta Drugs Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Beta Drugs Ltd.?
Investor presentations and annual day presentations of Beta Drugs Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Beta Drugs Ltd.?
Corporate announcements and regulatory filings of Beta Drugs Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Beta Drugs Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Beta Drugs Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Beta Drugs Ltd.?
The ISIN (International Securities Identification Number) of Beta Drugs Ltd. is INE351Y01019. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Beta Drugs Ltd. listed?
Beta Drugs Ltd. is listed on NSE and BSE. The NSE symbol is BETA and the BSE code is -.
Where can I find the shareholding pattern of Beta Drugs Ltd.?
The quarterly shareholding pattern of Beta Drugs Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Beta Drugs Ltd. on Sharpely?
Share price data for Beta Drugs Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.